Perspectives on cellular dysfunction in nonalcoholic steatohepatitis: a case of ‘multiorganelle failure’? Proceedings of a virtual workshop on nonalcoholic steatohepatitis

References

• Zelman S. The liver in obesity. AMA Arch. Intern. Med.90, 141–156 (1952).
   PubMedGoogle Scholar
• Thaler H. [The fatty liver and its pathogenetic relation to liver cirrhosis]. Virchows Arch. Pathol. Anat. Physiol. Klin. Med.335, 180–210 (1962).
   PubMedGoogle Scholar
• Itoh S, Tsukada Y, Motomura Y, Ichinoe A. Five patients with nonalcoholic diabetic cirrhosis. Acta Hepatogastroenterol. (Stuttg.)26, 90–97 (1979).
   PubMed Web of Science ®Google Scholar
• Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc.55, 434–438 (1980).
   PubMed Web of Science ®Google Scholar
• Batman PA, Scheuer PJ. Diabetic hepatitis preceding the onset of glucose intolerance. Histopathology9, 237–243 (1985).
   PubMed Web of Science ®Google Scholar
• Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology95, 1056–1062 (1988).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Bellini M, Tondelli E et al. Nonalcoholic steatohepatitis and the ‘bright liver syndrome’: should a recently expanded clinical entity be further expanded? Am. J. Gastroenterol.90, 2072–2074 (1995).
   PubMed Web of Science ®Google Scholar
• Mendler MH, Turlin B, Moirand R et al. Insulin resistance-associated hepatic iron overload. Gastroenterology117, 1155–1163 (1999).
   PubMed Web of Science ®Google Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol.94, 2467–2474 (1999).
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M et al.; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology41, 1313–1321 (2005).
   PubMed Web of Science ®Google Scholar
• Dianzani MU. Uncoupling of oxidative phosphorylation in mitochondria from fatty livers. Biochim. Biophys. Acta14, 514–532 (1954).
   PubMed Web of Science ®Google Scholar
• Di Luzio NR, Costales F. Inhibition of the ethanol and carbon tetrachloride induced fatty liver by antioxidants. Exp. Mol. Pathol.4, 141–154 (1965).
   PubMed Web of Science ®Google Scholar
• Adinolfi LE, Restivo L. Does vitamin E cure nonalcoholic steatohepatitis? Expert Rev. Gastroenterol. Hepatol.5(2), 147–150 (2011).
   PubMed Web of Science ®Google Scholar
• Caldwell SH, Swerdlow RH, Khan EM et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J. Hepatol.31, 430–434 (1999).
   PubMed Web of Science ®Google Scholar
• Jayakumar S, Guillot S, Argo C, Redick J, Caldwell S. Ultrastructural findings in human nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol.5(2), 141–145 (2011).
   PubMed Web of Science ®Google Scholar
• Falk Symposium 121 Steatohepatitis (NASH and ASH). Leuschner U, James O, Dancygier H (Eds). Kluwier Academics Publishers, Berlin, Germany (2001).
   Google Scholar
• Sanyal AJ; American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology123, 1705–1725 (2002).
   PubMedGoogle Scholar
• Fatty Liver Disease. NASH and Related Disorders. Farrell GC, George J, De La M Hall P, McCullough AJ (Eds). Blackwell Publishing, NJ, USA (2005).
   Google Scholar
• Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J. Hepatol.44, 197–208 (2006).
   PubMed Web of Science ®Google Scholar
• Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J. Hepatol.53, 372–384 (2010).
   PubMed Web of Science ®Google Scholar
• Loria P, Adinolfi LE, Bellentani S et al.; NAFLD Expert Committee of the Associazione Italiana per lo studio del Fegato. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig. Liver Dis.42, 272–282 (2010).
   PubMedGoogle Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med.23, 469–480 (2006).
   PubMed Web of Science ®Google Scholar
• Loria P, Lonardo A, Carulli N. Should nonalcoholic fatty liver disease be renamed? Dig. Dis.23, 72–82 (2005).
   PubMed Web of Science ®Google Scholar
• Brunt EM. What’s in a name? Hepatology50, 663–667 (2009).
   PubMed Web of Science ®Google Scholar
• Loomba R, Wesley R, Pucino F, Liang TJ, Kleiner DE, Lavine JE. Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trials. Clin. Gastroenterol. Hepatol.6, 1243–1248 (2008).
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. DOI: 10.3109/07853890.2010.518623 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Lonardo A, Adinolfi LE, Loria P. Mechanisms of hepatitis C virus-induced fatty liver disease. Hot Topics Viral Hepatitis5, 23–28 (2009).
   Google Scholar
• Pattullo V, Douglas MW, George J. Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis? Expert Rev. Gastroenterol. Hepatol.5(2), 265–277 (2011).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Bellentani S, Ratziu V, Loria P. Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies? Expert Rev. Gastroenterol. Hepatol.5(2), 279–289 (2011).
   PubMed Web of Science ®Google Scholar
• Arrese M. Burning hepatic fat: therapeutic potential for liver-specific thyromimetics in the treatment of nonalcoholic fatty liver disease. Hepatology49, 348–351 (2009).
   PubMed Web of Science ®Google Scholar
• Marchesini G, Ridolfi V, Nepoti V. Hepatotoxicity of fast food? Gut57, 568–570 (2008).
   PubMed Web of Science ®Google Scholar
• Struben VM, Hespenheide EE, Caldwell SH. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am. J. Med.108, 9–13 (2000).
   PubMed Web of Science ®Google Scholar
• Caldwell SH, Harris DM, Patrie JT, Hespenheide EE. Is NASH underdiagnosed among African Americans? Am. J. Gastroenterol.97, 1496–1500 (2002).
   PubMed Web of Science ®Google Scholar
• Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology40, 1387–1395 (2004).
   PubMed Web of Science ®Google Scholar
• Daly AK, Ballestri S, Carulli L, Loria P, Day CP. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. Expert Rev. Gastroenterol. Hepatol.5(2), 253–263 (2011).
   PubMed Web of Science ®Google Scholar
• Lombardi B, Pani P, Schlunk FF. Choline-deficiency fatty liver: impaired release of hepatic triglycerides. J. Lipid Res.9, 437–446 (1968).
   PubMed Web of Science ®Google Scholar
• Tarugi P, Lonardo A, Ballarini G et al. Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B. Gastroenterology111, 1125–1133 (1996).
   PubMed Web of Science ®Google Scholar
• Pereira IVA, Stefano JT, Oliveira CPMS. Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease. Expert Rev. Gastroenterol. Hepatol.5(2), 245–251 (2011).
   PubMed Web of Science ®Google Scholar
• Romeo S, Kozlitina J, Xing C et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet.40, 1461–1465 (2008).
   PubMed Web of Science ®Google Scholar
• Browning JD, Cohen JC, Hobbs HH. Patatin-like phospholipase domain-containing and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease. Hepatology52, 1189–1192 (2010).
   PubMed Web of Science ®Google Scholar
• Ricchi M, Odoardi MR, Carulli L et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J. Gastroenterol. Hepatol.24, 830–840 (2009).
   PubMed Web of Science ®Google Scholar
• Bass NM. Lipidomic dissection of nonalcoholic steatohepatitis: moving beyond foie gras to fat traffic. Hepatology51, 4–7 (2010).
   PubMed Web of Science ®Google Scholar
• Sanyal AJ. Insulin resistance and tissue repair: a ‘fato-logical’ phenomenon. Gastroenterology125, 1886–1889 (2003).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature444, 860–867 (2006).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Lombardini S, Scaglioni F et al. Hepatic steatosis and insulin resistance: does etiology make a difference? J. Hepatol.44, 190–196 (2006).
   PubMed Web of Science ®Google Scholar
• Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J. Hepatol.51, 371–379 (2009).
   PubMed Web of Science ®Google Scholar
• Harmon RC, Tiniakos DG, Argo CK. Inflammation in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol.5(2), 189–200 (2011).
   PubMed Web of Science ®Google Scholar
• De Minicis S, Svegliati-Baroni G. Fibrogenesis in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol.5(2), 179–187 (2011).
   PubMed Web of Science ®Google Scholar
• Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA282, 1659–1664 (1999).
   PubMed Web of Science ®Google Scholar
• Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation68, 780–784 (1999).
   PubMed Web of Science ®Google Scholar
• Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat. Rec. (Hoboken)291, 684–692 (2008).
   PubMedGoogle Scholar
• Caldwell SH, de Freitas LA, Park SH et al. Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis. Hepatology49, 1888–1895 (2009).
   PubMed Web of Science ®Google Scholar
• Serviddio G, Bellanti F, Vendemiale G, Altomare E. Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol.5(2), 233–244 (2011).
   PubMed Web of Science ®Google Scholar
• Machado MV, Cortez-Pinto H. Cell death and nonalcoholic steatohepatitis: where is ballooning relevant? Expert Rev. Gastroenterol. Hepatol.5(2), 213–222 (2011).
   PubMed Web of Science ®Google Scholar
• Alkhouri N, Carter-Kent C, Feldstein AE. Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert Rev. Gastroenterol. Hepatol.5(2), 201–212 (2011).
   PubMed Web of Science ®Google Scholar
• Amir M, Czaja MJ. Autophagy in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol.5(2), 159–166 (2011).
   PubMed Web of Science ®Google Scholar
• Lonardo A, Loria P. NAFLD and cardiovascular risk: direct evidence for the tale of two ages. Am. J. Gastroenterol.104, 1851–1852 (2009).
   PubMed Web of Science ®Google Scholar
• Lackner C. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist’s perspective. Expert Rev. Gastroenterol. Hepatol.5(2), 223–231 (2011).
   PubMed Web of Science ®Google Scholar
• Caldwell S, Ikura Y, Dias D et al. Hepatocellular ballooning in NASH. J. Hepatol.53, 719–723 (2010).
   PubMed Web of Science ®Google Scholar
• Molnar A, Haybaeck J, Lackner C, Strnad P. The cytoskeleton in nonalcoholic steatohepatitis – 100 years old but still youthful. Expert Rev. Gastroenterol. Hepatol.5(2), 167–177 (2011).
   PubMed Web of Science ®Google Scholar